OVID
Ovid Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.69
−0.37%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+18.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 8, 2026 | Carter Charles Ross · officer: Chief Financial Officer | A-Award | 50,000 | $0.00 |
| Jun 17, 2026 | Greka Anna · director | A-Award | 130,000 | $2.26 |
| Apr 9, 2026 | PAPADOPOULOS STELIOS · director | A-Award | 17,578 | $2.56 |
| Apr 9, 2026 | Fitzgerald Kevin Joseph · director | A-Award | 17,578 | $2.56 |
| Apr 9, 2026 | Friedman Bart · director | A-Award | 8,789 | $2.56 |
| Mar 25, 2026 | LEVIN JEREMY M · director, officer: Executive Chairman | M-Exempt | 47,333 | $1.40 |
| Mar 2, 2026 | DUNCAN BARBARA GAYLE · director | A-Award | 65,000 | $1.65 |
| Mar 2, 2026 | Fitzgerald Kevin Joseph · director | A-Award | 65,000 | $1.65 |
| Mar 2, 2026 | LEVIN JEREMY M · director | A-Award | 957,000 | $1.65 |
| Mar 2, 2026 | PAPADOPOULOS STELIOS · director | A-Award | 65,000 | $1.65 |
| Mar 2, 2026 | Rona Jeffrey A · officer: CBFO | Sale | 8,541 | $1.45 |
| Mar 2, 2026 | Bernstein Karen · director | A-Award | 65,000 | $1.65 |
| Mar 2, 2026 | ALEXANDER MARGARET A. · director, officer: President and CEO | A-Award | 1,435,000 | $1.65 |
| Mar 2, 2026 | ALEXANDER MARGARET A. · director, officer: President and CEO | Sale | 11,656 | $1.45 |
| Mar 2, 2026 | Rona Jeffrey A · officer: CBFO | A-Award | 408,750 | $1.65 |
| Mar 2, 2026 | Rona Jeffrey A · officer: CBFO | A-Award | 68,125 | $0.00 |
| Mar 2, 2026 | Friedman Bart · director | A-Award | 65,000 | $1.65 |
| Jan 5, 2026 | ALEXANDER MARGARET A. · director, officer: President and CEO | A-Award | 890,000 | $1.76 |
| Dec 18, 2025 | LEVIN JEREMY M · director, officer: CEO | Purchase | 71 | $0.00 |
| Dec 18, 2025 | LEVIN JEREMY M · director, officer: CEO | Purchase | 47,333 | $1.40 |
| Dec 18, 2025 | LEVIN JEREMY M · director, officer: CEO | Purchase | 35,500 | $1.40 |
| Jun 18, 2025 | Friedman Bart · director | A-Award | 45,000 | $0.57 |
| Jun 18, 2025 | Bernstein Karen · director | A-Award | 45,000 | $0.57 |
| Jun 18, 2025 | Fitzgerald Kevin Joseph · director | A-Award | 45,000 | $0.57 |
| Jun 18, 2025 | Duncan Barbara Gayle · director | A-Award | 45,000 | $0.57 |
| Mar 4, 2025 | PAPADOPOULOS STELIOS · director | A-Award | 90,000 | $0.49 |
| Feb 28, 2025 | Rona Jeffrey A · officer: CBFO | Sale | 3,902 | $0.56 |
| Feb 28, 2025 | ALEXANDER MARGARET A. · officer: President and COO | Sale | 5,279 | $0.56 |
| Feb 24, 2025 | Rona Jeffrey A · officer: CBFO | A-Award | 262,500 | $0.57 |
| Feb 24, 2025 | LEVIN JEREMY M · director, officer: CEO | A-Award | 1,650,000 | $0.57 |
Institutional positioning
13F filings over the trailing two quarters
New 76Increased 65Reduced 52Sold out 17
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Jupiter Topco LLC | New Position | 20,741,234 | Aug 14, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | Increased | 11,812,241 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 10,823,480 | Aug 7, 2026 |
| JANUS HENDERSON GROUP PLC | New Position | 10,714,000 | May 18, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 10,714,000 | May 15, 2026 |
| AFFINITY ASSET ADVISORS, LLC | Increased | 10,636,318 | May 14, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Reduced | 10,500,968 | Aug 14, 2026 |
| Affinity Asset Advisors, LLC | Reduced | 10,144,562 | Aug 13, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | Increased | 9,916,911 | May 15, 2026 |
| STATE STREET CORP | Increased | 7,900,765 | Aug 7, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 7,760,114 | Aug 13, 2026 |
| ADAR1 Capital Management, LLC | Increased | 7,417,479 | Aug 14, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Increased | 6,719,076 | Aug 14, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Unchanged | 6,163,781 | Aug 14, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Increased | 6,163,781 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 8, 2026